Log In
BCIQ
Print this Print this
 

Alpelisib (BYL719)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionPhosphoinositide 3-kinase (PI3K) alpha inhibitor
Molecular Target Phosphoinositide 3-kinase (PI3K) alpha
Mechanism of ActionPhosphoinositide 3-kinase (PI3K) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/27/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today